search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


APPEAL-study Analysis of Predictive Parameters for Evident Anastomotic Leakage A Multicenter Cohort Study


- candidate number3144
- NTR NumberNTR1258
- ISRCTNISRCTN wordt niet meer aangevraagd
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR27-mrt-2008
- Secondary IDs2006-183 MEC
- Public TitleAPPEAL-study Analysis of Predictive Parameters for Evident Anastomotic Leakage A Multicenter Cohort Study
- Scientific TitleAPPEAL-study Analysis of Predictive Parameters for Evident Anastomotic Leakage A Multicenter Cohort Study
- ACRONYMAPPEAL-study
- hypothesisDrainage fluid of patients that received a primary colorectal anastomosis contains one or more biomarkers for anastomotic leakage that allow diagnosis of this complication in an early postoperative phase. The aim of this study is to identify these potential biomarkers.
- Healt Condition(s) or Problem(s) studiedAnastomotic leakage, Colorectal surgery, Drainage fluid, Biomarkers
- Inclusion criteria1. All patients in which a drain has been placed at the anastomotic site after one of the following procedures:
- Left hemicolectomy
- Sigmoid resection
- Anterior resection (high & low)
- Total Mesorectal Excision
- Subtotal colectomy with ileo- rectal or ileo-anal anastomosis
2. Informed consent
3. Primary anastomosis
- Exclusion criteria1. Pregnancy
2. Age < 18 years
3. Refusing to participate
4. Urgent operation
5. No drain
- mec approval receivedyes
- multicenter trialyes
- randomisedno
- group[default]
- Type2 or more arms, non-randomized
- Studytypeintervention
- planned startdate 2-feb-2007
- planned closingdate2-aug-2009
- Target number of participants273
- InterventionsProphylactic drainage after colorectal surgery is common practice. When a drain is left behind during operation the patient can be included in the study. The only difference with routine practice is that the drain will stay in place until the fifth postoperative day, which is longer than in routine practice. When complications or discomfort occurs before this term the drain will be removed.
- Primary outcomeThe primary outcome measure of the APPEAL-study is anastomotic leakage, defined as an insufficiency of the anastomosis, demonstrated by either endoscopy, radiologic studies or operation and leading to a clinical state that requires an intervention. These interventions are:
a) Therapeutic drainage
b) Use of therapeutic antibiotics
c) Any surgical intervention, for example:
• Construction diverting stoma
• Construction new anastomosis
• Surgical disconnection of the anastomosis
• Suturing
- Secondary outcomeComparison of the studied potential biomarkers in terms of speed, accuracy and cost-effectiveness Study the capacity of the potential biomarkers to distinguish between clinically manifest and subclinical anastomotic leakage
- TimepointsDrainage fluid will be taken from the drain during the first 5 postoperative days.
During the first postoperative consultation after approximately one month the patient will be evaluated for signs of anastomotic leakage.
Analysis of drainage fluid will be done when a sufficient number of samples is collected for efficient analysis.
- Trial web siteN/A
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIES N. Komen
- CONTACT for SCIENTIFIC QUERIESProf. Dr. J.F. Lange
- Sponsor/Initiator Erasmus Medical Center
- Funding
(Source(s) of Monetary or Material Support)
Technologiestichting STW (Stichting Technische Wetenschappen)
- PublicationsN/A
- Brief summaryThe main complication after colorectal surgery is anastomotic leakage (AL), with an incidence varying between 5% and 15%. In an insufficient anastomosis, wall defects can develop through which non-sterile contents of the colon can leak into the abdominal or pelvic cavity. This can cause severe infections that can lead to sepsis, multiple organ failure and death. Mortality rates are approximately 10% to 20%. Observation of clinical signs and symptoms of AL, the current diagnostic tools, is not very specific. They can mimic several common, less severe, postoperative infections. Diagnostic tests for these infections can delay the actual diagnosis. On top of that, when AL has already progressed to a state of clinical manifestation, the patient is already ill and treatment should be initiated. Imaging modalities, more specific abdominal CT-scans and contrast enemas, are normally used to confirm a clinical diagnosis of AL (4). This means that imaging is done when the patient has already shown signs and symptoms and treatment has to be initiated. In short, it can be stated there is much need for an objective biomarker of AL.
An accepted method for prevention of complications of AL after colorectal surgery is prophylactic drainage. This enables postoperative evacuation of blood and wound fluid collections and therefore decreases the risk of infection. The aim of the APPEAL-study is to analyse these collections, retrieved from the drain’s reservoir, for potential biomarkers of AL in an early stage. Drainage fluid will be collected during 5 days. The fluid will be processed in the laboratory of microbiology, where a culture is done and the remaining fluid is centrifugated and frozen for later, in batch, analysis. The clinical chemical tests will be done in batch in the Erasmus MC. The cultures, centrifugation and freezing of the fluids will be done at the laboratory of microbiology of the participating medical center. The results of the cultures and clinical chemical analyses will be known for the researcher, not for the patient and not for the medical doctors treating the patient. The results of the group with anastomotic leakage will be compared with the results of the group without anastomotic leakage in order to define one or more biomarkers.
- Main changes (audit trail)
- RECORD27-mrt-2008 - 7-apr-2008


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl